Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Bionic Eye Technologies

Bionic Eye Technologies
2012 FOUNDED
PRIVATE STATUS
Corporate LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer and manufacturer of medical devices designed to assist visually impaired patients. The company's products include retinal prosthesis that is used in the sub-retinal area of the eye and provides lower risk of eye infection, reduced erosion through the delicate tissues that cover the front of the eye and the ability to place stimulating electrodes closer to retinal nerve cells, enabling the patients to enhance visual outcomes.

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Primary Office
  • 239 Cherry Street
  • Suite 1B
  • Ithaca, NY 14850
  • United States

+1 (607) 000-0000

Bionic Eye Technologies Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Bionic Eye Technologies‘s full profile, request access.

Request full access to PitchBook

Bionic Eye Technologies Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Bionic Eye Technologies‘s full profile, request access.

Request full access to PitchBook

Bionic Eye Technologies Executive Team (5)

Name Title Board
Seat
Contact
Info
Richard Birney Chief Executive Officer & Chairman of Board
Douglas Shire Ph.D Chief Technology Officer
Joseph Rizzo III Co-Founder & Medical Director
John Wyatt Ph.D Co-Founder

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

Bionic Eye Technologies Board Members (1)

Name Representing Role Since Contact
Info
0000000 000000 Bionic Eye Technologies Chief Executive Officer & Chairman of Board 000 0000